A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010

Kidney International

Volumn 88, Issue 5, 2015, Pages 950-957

  Mills, Katherine T ^a   Xu, Yu ^a,b   Zhang, Weidong ^c   Bundy, Joshua D ^a   Chen, Chung Shiuan ^a   Kelly, Tanika N ^a   Chen, Jing ^a,d   He, Jiang ^a,d  

^a TULANE UNIVERSITY   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Prevalence; Proteinuria

Indexed keywords

AGE DISTRIBUTION; CHRONIC KIDNEY DISEASE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; GEOGRAPHIC DISTRIBUTION; HUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX RATIO; FEMALE; HEALTH; MALE; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA;

DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; GLOBAL HEALTH; HUMANS; MALE; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84947614813     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.230     Document Type: Article

References (54)

1. Jha V, Garcia-Garcia G, Iseki K et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-272.
2. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
3. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
4. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 385: 117-171.
5. Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One 2013; 8: e72860.
6. U. S. Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2012.
7. Danaei G, Finucane MM, Lu Y et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 27 million participants. Lancet 2011; 378: 31-40.
8. Danaei G, Finucane MM, Lin JK et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 54 million participants. Lancet 2011; 377: 568-577.
9. White SL, Polkinghorne KR, Atkins RC et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010; 55: 660-670.
10. Arora P, Vasa P, Brenner D et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013; 185: E417-E423.
11. National Health Survey in Chile 2009-2010. http://epi. minsal. cl/estudios-yencuestas-poblacionales/encuestas-poblacionales/encuesta-nacional-desalud/resultados-ens/, Accessed 17 April 2014.
12. Juutilainen A, Kastarinen H, Antikainen R et al. Trends in estimated kidney function: the FINRISK surveys. Eur J Epidemiol 2012; 27: 305-313.
13. Bongard V, Dallongeville J, Arveiler D et al. Assessment and characteristics of chronic renal insufficiency in France. Ann Cardiol Angeiol (Paris) 2012; 61: 239-244, in French.
14. Zhang QL, Koenig W, Raum E et al. Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009; 48: 122-127.
15. Cirillo M, Laurenzi M, Mancini M et al. Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int 2006; 70: 800-806.
16. Gambaro G, Yabarek T, Graziani MS et al. Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol 2010; 5: 1946-1953.
17. Imai E, Horio M, Watanabe T et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630.
18. Horio M, Imai E, Yasuda Y et al. Modification of the CKD Epidemiology Collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 2010; 56: 32-38.
19. Kang HT, Lee J, Linton JA et al. Trends in the prevalence of chronic kidney disease in Korean adults: the Korean National Health and Nutrition Examination Survey for 1998 to 2009. Nephrol Dial Transplant 2013; 28: 927-936.
20. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284.
21. Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333: 1047.
22. Vinhas J, Gardete-Correia L, Boavida JM et al. Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: data from the PREVADIAB study. Nephron Clin Pract 2011; 119: c35-c40.
23. Alsuwaida AO, Farag YMK, Al Sayyari AA et al. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi Investigators)-a pilot study. Saudi J Kidney Dis Transplant 2010; 21: 1066-1072.
24. National Health Survey in Singapore 2010. https://www. moh. gov. sg/content/moh-web/home/Publications/Reports/2011/national-health- survey2010. html, Accessed 17 April 2014.
25. Sabanayagam C, Lim SC, Wong TY et al. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 2564-2570.
26. Otero A, de Francisco A, Gayoso P et al. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia 2010; 30: 78-86 in Spanish.
27. Nitsch D, Felber Dietrich D, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21: 935-944.
28. Health Survey for England 2010. http://www. hscic. gov. uk/catalogue/PUB03023/heal-surv-eng-2010-resp-heal-ch8-kidn. pdf, Accessed 17 April 2014.
29. National Health and Nutrition Examination Survey 2007-2008, 2009-2010, 2011-2012. http://www. cdc. gov/nchs/nhanes/nhanes-questionnaires. htm, Accessed 17 April 2014.
30. Rubinstein AL, Irazola VE, Poggio R et al. Detection and follow-up of cardiovascular disease and risk factors in the Southern Cone of Latin America: the CESCAS I study. BMJ Open 2011; 1: e000126.
31. Salazar MR, Carbajal HA, Marillet AG et al. Glomerular filtration rate, cardiovascular risk factors and insulin resistance. Medicina (B Aires) 2009; 69: 541-546 in Spanish.
32. Cravedi P, Sharma SK, Bravo RF et al. Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA. BMJ Open 2012; 2: e001357.
33. Zhang L, Wang F, Wang L et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822.
34. Sumaili EK, Krzesinski JM, Zinga CV et al. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant 2009; 24: 117-122.
35. Orantes CM, Herrera R, Almaguer M et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa Study, 2009. MEDICC Rev 2011; 13: 14-22.
36. Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors. J Nephrol 2009; 22: 99-108.
37. Codreanu I, Sali V, Gaibu S et al. Prevalence of hypertension and diabetes and coexistence of chronic kidney disease and cardiovascular risk in the population of the Republic of Moldova. Int J Hypertens 2012; 2012: 951734.
38. Ulasi II, Ijoma CK, Onodugo OD et al. Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria. Kidney Int Suppl 2013; 3: S195-S201.
39. Jessani S, Bux R, Jafar TH. Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan-a community based cross-sectional study. BMC Nephrol 2014; 15: 90.
40. Cepoi V, Onofriescu M, Segall L et al. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons. Int Urol Nephrol 2012; 44: 213-220.
41. Matsha TE, Yako YY, Rensburg MA et al. Chronic kidney diseases in mixed ancestry South African populations: prevalence, determinants and concordance between kidney function estimators. BMC Nephrol 2013; 14: 75.
42. Ong-Ajyooth L, Vareesangthip K, Khonputsa P et al. Prevalence of chronic kidney disease in Thai adults: a national health survey. BMC Nephrol 2009; 10: 35.
43. Süleymanlar G, Uta? C, Arinsoy T et al. A population-based survey of chronic renal disease in Turkey-the CREDIT study. Nephrol Dial Transplant 2011; 26: 1862-1871.
44. Glassock RJ. Estimated glomerular filtration rate: time for a performance review? Kidney Int 2009; 75: 1001-1003.
45. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382.
46. Tonelli M, Riella M. Chronic kidney disease and the ageing population. Lancet 2014; 383: 1278-1279.
47. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
48. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150.
49. Glassock RJ, Winearls C. The global burden of chronic kidney disease: how valid are the estimates? Nephron Clin Pract 2008; 110: c39-c47.
50. World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013 to 2020. http://www. who. int/nmh/events/ncd- action-plan/en/, Accessed 31 October 2014.
51. Zoccali C, Kramer A, Jager KJ. Epidemiology of CKD in Europe: an uncertain scenario. Nephrol Dial Transplant 2010; 25: 1731-1733.
52. The World Bank Country and Lending Groups. http://data. worldbank. org/about/country-classifications/country-and-lending-groups, Accessed 17 April 2014.
53. World population prospects, the 2012 revision. http://esa. un. org/unpd/wpp/index. htm, Accessed 17 April 2014.
54. Efron B. Bootstrap methods: another look at the jackknife. Ann Statist 1979; 7: 1-26.